Drug Detail:Diphtheria and tetanus toxoids (monograph) (Medically reviewed)
Drug Class:
Usual Pediatric Dose for Diphtheria Prophylaxis
0.5 mL intramuscularly in a 5-dose series (at 2, 4, 6, and 15 to 18 months, and at 4 to 6 years)
Comments:
- The first dose may be given at 6 weeks of age.
Use: Active immunization against diphtheria and tetanus in children from 6 weeks to 6 years
Usual Pediatric Dose for Tetanus Prophylaxis
0.5 mL intramuscularly in a 5-dose series (at 2, 4, 6, and 15 to 18 months, and at 4 to 6 years)
Comments:
- The first dose may be given at 6 weeks of age.
Use: Active immunization against diphtheria and tetanus in children from 6 weeks to 6 years
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Serious hypersensitivity (e.g. anaphylaxis) to any of the ingredients
Safety and efficacy have not been established in patients younger than 6 weeks; this drug is not recommended for use in these patients.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- The anterolateral aspect of the thigh is the preferred injection site for children under 1 year old.
- The deltoid may be used for older children.
Storage requirements:
- Refrigerate; do not freeze
IV compatibility:
- Do not mix with any other vaccine.